eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
5/2021
vol. 38
 
Share:
Share:
more
 
 
abstract:
Letter to the Editor

A case of adult-onset Still’s disease accompanied with pulmonary tuberculosis successfully treated with colchicine

Shijia Rao
1
,
Wei Shi
2

1.
Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2.
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China
Adv Dermatol Allergol 2021; XXXVIII (5): 912-915
Online publish date: 2021/11/05
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
A 54-year-old man admitted to our department presented with recurrent fever for 18 months with arthralgia and skin rash in May 2018. The patient appeared to have run a fever with no obvious cause since December 2016. His highest body temperature was 41°C, accompanied by arthralgia and myalgia, the laboratory examination showed the following: white blood cells (WBC) 12.59 × 109/l (3.5–9.5 × 109/l) with neutrophils 75.3% (40–75%); C-reactive protein (CRP) 65.8 mg/l (0–8 mg/l), erythrocyte sedimentation rate (ESR) 87 mm/h (0–15 mm/h), negative for cytomegalovirus (CMV), EBV-DNA, TORCH, ANA, ds-DNA, SSA, SSB, anti-Sm, RF, ANCA, mycoplasma, and chlamydia. Procalcitonin (PCT) 0.11 ng/ml (< 0.05 ng/ml). Pulmonary computed tomography (CT) showed nodules and chordal shadows in the right upper lung with partial calcification and mediastinal lymphadenopathy. T-spot result showed 247.4 pg/ml (< 14 pg/ml), but was negative for acid-fast staining of sputum. The patient had been in remission from pulmonary tuberculosis history for 30 years.
Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.